Hans Bos Group

Ras proteins and cancer

Our Focus

The aim of our group is to understand the regulation and function of Ras-like small GTPases. Ras is the paradigm of the family and mutated in 15% of all human cancers. Rap is a very close relative that functions in among others cell adhesion, integrity of cell junctions, cell migration, cell polarity and secretion. The group has used biochemical, cell biological, and proteomic approaches to study the spatial and temporal control and the molecular mechanism of the function of Ras and Rap.

Central in these studies have been the Epac proteins identified in our lab as a cAMP-regulated guanine nucleotide exchange factor for Rap in 1998. Due to development of a selective cAMP analog 8-CPT-2'OMe-cAMP or as we call it 007, many process in which Epac plays a role have been eluded and currently the protein is one of the centerpieces in cAMP research.

Recently the group has adopted the organoid culture system developed by Hans Clevers as a model system to study signal transduction in cell complexes. This includes the development of systems to perform high-end live-imaging of signalling events. Using these organoids we are currently exploring the mechanism of resistance and possible solutions of mutant Ras tumors for targeted drugs.

Bas Ponsioen Post Doc
Ester Frische

Ester Frische

Ester is a biomedical scientist by training with experience in both an academic and a biotech environment. She obtained her PhD in the lab of Hans Bos at the UMC Utrecht. She studied signalling routes in cancer biology and continued this line of research at Galapagos in Leiden. In 2010 Ester moved into scientific project management and is managing director of CancerGenomics.nl since 2015. She has been involved with Oncode Institute since its early days and supported the founders in developing the scientific strategy. In her current role as Programme Manager, Ester supports the Scientific Director and Research Management Committee and is responsible for all programmes directly related to supporting research and the link to the clinic. This includes managing dedicated funds for clinical proof of concept projects and large equipment and technology applications.
Fried Zwartkruis Associate Professor
Ingrid Verlaan Technician
Jeanine Roodhart Clinician Scientist
Lucas Bruurs Post Doc
Nizar Hami Technician
Sander Mertens Technician
Susan Zwakenberg Technician
Contact Information
Hans Bos Oncode Investigator

More Research

Research Strategy
Focus and Approach
Over 800 scientists working under a single strategy. Oncode is all about uniting efforts and bringing focus to research.
Support Programme
Our supporting programmes
New plans that help fulfil Oncode's objectives get our full support. Young talents are matched with mentors on the basis of their personal endeavours.